Loading chat...

NJ A6151

Bill

Status

Introduced

12/4/2025

Primary Sponsor

Lisa Swain

Click for details

Origin

General Assembly

2024-2025 Regular Session

AI Summary

  • Over-the-counter and prescription drugs containing ingredients derived from major food allergens or gluten-containing grains must bear labels clearly identifying those ingredients and specifying the type of gluten-containing grain where applicable

  • Drugs failing to comply with labeling requirements will be deemed misbranded, and the Commissioner of Health may order label corrections within a specified timeframe

  • Penalties for misbranding violations are $500 for a first offense, $1,000 for a second offense, and $2,000 for third and subsequent offenses

  • The Department of Health is authorized to investigate labeling accuracy and will adopt rules and regulations to implement the requirements

  • The act takes effect 25 months after enactment to allow manufacturers time to comply with the new labeling standards

Legislative Description

Requires labeling of over-the-counter and prescription drugs containing major food allergen or gluten-containing grain.

Health

Last Action

Introduced, Referred to Assembly Health Committee

12/4/2025

Committee Referrals

Health12/4/2025

Full Bill Text

No bill text available